[Federal Register Volume 73, Number 48 (Tuesday, March 11, 2008)]
[Notices]
[Pages 13006-13007]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-4564]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

     Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel Advanced Development of Multivalent 
Filovirus (Ebola and Marburg) Hemorrhagic Fever Vaccines.
     Date: March 20, 2008.
     Time: 8 a.m. to 6 p.m.
     Agenda: To review and evaluate contract proposals.
     Place: Crowne Plaza Washington DC Silver Spring, 8777 Georgia 
Avenue, Silver Spring, MD 20910.
     Contact Person: Lynn Rust, PhD, Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, 
National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 
7616, Bethesda, MD 20892, (301) 402-3938, [email protected].

[[Page 13007]]

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: March 3, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
 [FR Doc. E8-4564 Filed 3-10-08; 8:45 am]
BILLING CODE 4140-01-M